cancer clinical trials in vallejo, CA

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Kaiser Permanente Medical Center - Vallejo
Vallejo, California 94589

Colorectal Cancer

Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Sutter Solano Medical Center
Vallejo, California 94589

Head and Neck Cancer

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Kaiser Permanente Medical Group, Northern California
Vallejo, California 94589

Androgen Independent Prostate Cancer (AIPC), Non Small Cell Lung Cancer (NSCLC)

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

Sutter Solano Medical Center
Vallejo, California 94589

Prostate Cancer

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Sutter Solano Medical Center

Trial Locations
Sutter Solano Medical Center
Kaiser Permanente-Vallejo

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

Sutter Solano Medical Center

Trial Locations
Sutter Solano Medical Center
Kaiser Permanente Medical Center
Kaiser Permanente-Vallejo

Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer

Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery

Kaiser Permanente-Vallejo
Vallejo, California 94589

Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Sutter Solano Medical Center
Vallejo, California 94589

Prostate Cancer

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

Sutter Solano Medical Center
Vallejo, California 94589

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer

Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer

Kaiser Permanente Medical Center - Vallejo

Trial Locations
Kaiser Permanente Medical Center - Vallejo
Sutter Solano Medical Center

Breast Cancer

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Sutter Solano Medical Center
Vallejo, California 94589

Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor

Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer

Sutter Solano Medical Center

Trial Locations
Sutter Solano Medical Center
Kaiser Permanente-Vallejo

Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer

S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer

Kaiser Permanente Medical Center - Vallejo
Vallejo, California 94589

Lung Cancer

Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Kaiser Permanente Medical Center - Vallejo
Vallejo, California 94589

Lung Cancer

Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer

Kaiser Permanente-Vallejo
Vallejo, California 94589

Breast Cancer

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Kaiser Permanente - California Northern Kaiser Med

Trial Locations
Kaiser Permanente - California Northern Kaiser Med
Kaiser Permanente - California Northern Vallejo Med Center/Med Offices

Myelogenous Leukemia, Chronic

Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Sutter Solano Medical Center
Vallejo, California 94589

Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific

Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Kaiser Permanente Medical Center
Vallejo, California 94589

Recurrent Mantle Cell Lymphoma

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Sutter Solano Medical Center
Vallejo, California 94589

Prostate Cancer

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

Sutter Solano Medical Center

Trial Locations
Sutter Solano Medical Center
Kaiser Permanente Medical Center